Company Filing History:
Years Active: 1994
Title: Alan P Kendal: Innovator in Influenza Research
Introduction
Alan P Kendal is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of influenza research, particularly through his innovative work on the expression of influenza A M2 protein.
Latest Patents
Kendal holds a patent for the "Expression of influenza A M2 protein in baculovirus." This invention relates to baculovirus-expressed influenza antigens, specifically the influenza A membrane protein, M2, which is expressed from Autographa Californica nuclear polyhedrosis virus (AcNPV). The patent also describes a method to enhance the yield of baculovirus-expressed M2 proteins in host cells by culturing the recombinant baculovirus-infected host cells with an amantadine-like drug. Furthermore, this invention provides a means to utilize baculovirus-expressed M2 proteins in reproducible and routine assays for the serodiagnosis of influenza A virus infections, serving as an alternative to traditional methods such as complement fixation and hemagglutination tests. Kendal has 1 patent to his name.
Career Highlights
Kendal is associated with the United States of America as represented by the Department of Health. His work has been pivotal in advancing the understanding and diagnosis of influenza A virus infections.
Collaborations
Throughout his career, Kendal has collaborated with esteemed colleagues, including Renee Black and Paul A Rota. Their combined efforts have contributed to the progress in influenza research and diagnostics.
Conclusion
Alan P Kendal's innovative work in the field of influenza research has led to significant advancements in the diagnosis and understanding of the virus. His contributions continue to impact public health and scientific research.